Market Cap (In INR)
43.03 Billion
Revenue (In INR)
26.15 Billion
Net Income (In INR)
-1.53 Billion
Avg. Volume
114.9 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 132.75-307.8
- PE
- -
- EPS
- -
- Beta Value
- 1.236
- ISIN
- INE385W01011
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Arpit Janmejay Vyas
- Employee Count
- -
- Website
- https://imdcal.com
- Ipo Date
- 2017-09-21
- Details
- Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.
More Stocks
-
CESDF
-
NJR
-
LUPINLupin Limited
LUPIN
-
REFEXRefex Industries Limited
REFEX
-
AUSTAustin Gold Corp.
AUST
-
AMAT
-
SJVNSJVN Limited
SJVN
-
MEEC